Acute Optic Neuritis

Optic Neuritis RENEW Trial Results

Optic Neuritis RENEW Trial Results

By

The human monoclonal antibody opicinumab may potentially enhance spontaneous remyelination after acute optic neuritis.

Sign Up for Free e-Newsletters